Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry

ConclusionsOur findings suggest that females and males might differently benefit from the same dose of RASI/ARNI, and do represent a general call for randomized controlled trials to consider sex-specific up-titration schemes when testing HFrEF treatments in need of up-titration.

Source: European Journal of Heart Failure - May 2, 2024 Category: Cardiology Authors: Amerigo Ferrari, Davide Stolfo, Alicia Uijl, Nicola Orsini, Lina Benson, Gianfranco Sinagra, Peter Mol, Sieta T. de Vries, Ulf Dahlstr öm, Giuseppe Rosano, Lars H. Lund, Gianluigi Savarese Tags: Review Article Source Type: research